Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of NVP-1205 vs Rosuvastatin + Ezetimibe in Healthy Volunteers
NCT02029625Phase 1Completed
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- Feb 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ezetimibe + rosuvastatin in dyslipidemia (2 arms), sponsored by NVP Healthcare Co., Ltd. Primary endpoint: Area Under the Curve to the Last Measurable Concentration. Started Feb 2014; status: completed.
02
Drugs
ezetimibe + rosuvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02029625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02029625.